D.E. Shaw & Co
ACIU icon

D.E. Shaw & Co’s AC Immune ACIU Stock Holding History

D.E. Shaw & Co’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-14,716
Closed -$112K – 4723
2021
Q1 		$112K Buy
14,716
+3,804
+35% +$27.2K ﹤0.01% 3920
2020
Q4 		$56K Buy
+10,912
New +$55.7K ﹤0.01% 3842
2020
Q3 		– Sell
-33,159
Closed -$223K – 3779
2020
Q2 		$223K Sell
33,159
-11,755
-26% -$85.4K ﹤0.01% 3738
2020
Q1 		$310K Buy
+44,914
New +$351K ﹤0.01% 3453

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return

D.E. Shaw & Co's ACIU Position: Q2 2021 in Review

D.E. Shaw & Co sold out of AC Immune (ACIU) in Q2 2021, closing a stake of 14,716 shares — an estimated $112K sold.

D.E. Shaw & Co first reported a position in ACIU in Q1 2020 and held it in 4 quarters. The position peaked at $310K in Q1 2020. 57 funds tracked by Wall St. Rank hold ACIU as of Q2 2021.

  • D.E. Shaw & Co reported no remaining AC Immune position as of Q2 2021 after selling out during the quarter.
  • D.E. Shaw & Co sold 14,716 AC Immune shares in Q2 2021, an estimated $112K.
  • D.E. Shaw & Co first reported a position in AC Immune in Q1 2020 and held it in 4 quarters.
  • D.E. Shaw & Co's AC Immune position peaked at $310K in Q1 2020.
  • 57 funds tracked by Wall St. Rank held AC Immune as of Q2 2021.

Based on D.E. Shaw & Co's 13F filing for Q2 2021, filed 16 Aug 2021.